^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    onvatilimab (CI-8993)

    i
    Other names: CI-8993, JNJ-61610588, JNJ 61610588
    Associations
    News
    Trials
    Company:
    Curis, ImmuNext
    Drug class:
    VISTA antagonist
    Related drugs:
    Associations
    News
    Trials